Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Psoriasis"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 105308

Starter badań:

Tytuł:
Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi-ethnic Johor Bahru, Malaysia.
Autorzy:
Choon SE; Department of Dermatology, Hospital Sultanah Aminah Johor Bahru, Johor Bahru, Malaysia.; Clinical School Johor Bahru, Jeffrey Cheah School of Medicine & Health Sciences, Monash University, Kuala Lumpur, Malaysia.
Tok PSK; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Putrajaya, Malaysia.
Wong KW; Department of Dermatology, Hospital Sultanah Aminah Johor Bahru, Johor Bahru, Malaysia.
Lim YT; Department of Dermatology, Hospital Sultanah Aminah Johor Bahru, Johor Bahru, Malaysia.
Nanu NM; Department of Dermatology, Hospital Sultanah Aminah Johor Bahru, Johor Bahru, Malaysia.
Barker JN; St John's Institute of Dermatology at Guys and St Thomas's Hospitals and Kings College London, London, UK.
Capon F; Department of Medical and Molecular Genetics, King's College London, London, UK.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2023 Aug; Vol. 32 (8), pp. 1263-1271. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Interleukins*/genetics
Psoriasis*/epidemiology
Psoriasis*/ethnology
Psoriasis*/genetics
Female ; Humans ; Male ; Acute Disease ; Asian People ; Chronic Disease ; Malaysia ; Mutation ; Child ; Adolescent ; Young Adult ; Adult ; Middle Aged
Czasopismo naukowe
Szczegóły
Tytuł:
Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals.
Autorzy:
Wang Y; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Wang X; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Gu X; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Pan J; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Ouyang Z; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Lin W; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Zhu W; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. Electronic address: .
Wang M; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China; Department of Mental Health Center, Xiangya Hospital, Central South University, Changsha, China. Electronic address: .
Su J; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of affective disorders [J Affect Disord] 2023 Sep 15; Vol. 337, pp. 27-36. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Arthritis, Psoriatic*/epidemiology
Arthritis, Psoriatic*/genetics
Depressive Disorder, Major*/epidemiology
Depressive Disorder, Major*/genetics
Mental Disorders*/epidemiology
Mental Disorders*/genetics
Psoriasis*/epidemiology
Psoriasis*/genetics
Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Szczegóły
Tytuł:
Prevalence and risk factors associated with psoriatic arthritis among patients with psoriasis.
Autorzy:
Loo YP; Department of Dermatology, Hospital Pulau Pinang, Penang, Malaysia.; Department of Medicine, Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur, Malaysia.
Loo CH; Department of Dermatology, Hospital Pulau Pinang, Penang, Malaysia.
Lim AL; Department of Medicine, Hospital Pulau Pinang, Penang, Malaysia.
Wong CK; Department of Medicine, Hospital Pulau Pinang, Penang, Malaysia.
Ali NBM; Department of Dermatology, Hospital Pulau Pinang, Penang, Malaysia.
Khor YH; Department of Dermatology, Hospital Pulau Pinang, Penang, Malaysia.
Tan WC; Department of Dermatology, Hospital Pulau Pinang, Penang, Malaysia.
Pokaż więcej
Źródło:
International journal of rheumatic diseases [Int J Rheum Dis] 2023 Sep; Vol. 26 (9), pp. 1788-1798. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Psoriatic*/diagnosis
Arthritis, Psoriatic*/epidemiology
Arthritis, Psoriatic*/complications
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Psoriasis*/complications
Humans ; Pregnancy ; Adult ; Middle Aged ; Female ; Prevalence ; Cross-Sectional Studies ; C-Reactive Protein/analysis ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Generalized pustular psoriasis occurring in a patient with multiple sclerosis during treatment with fingolimod.
Autorzy:
Ikumi N; Department of Dermatology, Kumagaya General Hospital, Saitama, Japan.; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
Fujita H; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2023 Sep; Vol. 50 (9), pp. e295-e296. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Letter
MeSH Terms:
Multiple Sclerosis*/drug therapy
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Etretinate*
Skin Diseases, Vesiculobullous*
Humans ; Fingolimod Hydrochloride/adverse effects ; Chronic Disease
Opinia redakcyjna
Szczegóły
Tytuł:
Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression.
Autorzy:
Tang L; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510000, China.; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Zhang B; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510000, China.; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Li G; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510000, China.; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Zhu Y; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Feng B; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Su Z; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Han W; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Huang H; School of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510000, China.
Li Q; School of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510000, China.
Wang M; Department of Rheumatology Clinical and Basic Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Chen Y; Department of Immunology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Liu H; Department of Immunology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Dai Z; Department of Immunology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Wu D; Department of Material Basis of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Li H; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Yang L; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Lu Y; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Ye Z; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Zheng G; State Key Laboratory of Dampness, Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, 111 Dade Road, Guangzhou, 510000, China. .; Guangdong-Hong Kong-Macau Joint Lab On Chinese Medicine and Immune Disease Research, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China. .; Department of Pharmacology of Traditional Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China. .; Department of Pathology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China. .
Pokaż więcej
Źródło:
Journal of natural medicines [J Nat Med] 2023 Sep; Vol. 77 (4), pp. 712-720. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Hydrolyzable Tannins*/pharmacology
Hydrolyzable Tannins*/therapeutic use
Psoriasis*/drug therapy
Psoriasis*/pathology
Humans ; Interleukin-17/metabolism ; Interleukin-17/pharmacology ; Interleukin-17/therapeutic use ; Tumor Necrosis Factor-alpha/metabolism ; Interleukin-6/metabolism ; S-Phase Kinase-Associated Proteins/metabolism ; Keratinocytes ; Cell Proliferation
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of self-reported and measured height and weight in patients with psoriasis.
Autorzy:
Mastroeni S; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy.
Sampogna F; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy. .
Uras C; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy.
De Angelis M; Dermatology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Rome, Italy.
Fusari R; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy.
Melo Salcedo N; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy.
Pallotta S; Dermatology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Rome, Italy.
Abeni D; Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Via Monti Di Creta 104, 00167, Rome, Italy.
Pokaż więcej
Źródło:
Archives of dermatological research [Arch Dermatol Res] 2023 Sep; Vol. 315 (7), pp. 2023-2026. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Obesity*
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Humans ; Self Report ; Body Mass Index ; Reproducibility of Results ; Body Weight ; Body Height
Czasopismo naukowe
Szczegóły
Tytuł:
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial.
Autorzy:
Strober B; Department of Dermatology, Yale University, New Haven, Connecticut; Central Connecticut Dermatology Research, Cromwell, Connecticut. Electronic address: .
Paul C; Toulouse University and INSERM Infinity, Toulouse, France.
Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
Thaçi D; Insititute and Centre for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Puig L; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, New York.
White K; UCB Pharma, Slough, United Kingdom.
Vanvoorden V; UCB Pharma, Brussels, Belgium.
Deherder D; UCB Pharma, Braine-l'Alleud, Belgium.
Gomez NN; Department of Dermatology, UCB Pharma, Monheim, Germany.
Eyerich K; Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Sep; Vol. 89 (3), pp. 486-495. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
COVID-19*
Psoriasis*
Humans ; Pandemics ; Treatment Outcome ; Severity of Illness Index ; Double-Blind Method ; Antibodies, Monoclonal/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
RasGRP1 influences imiquimod-induced psoriatic inflammation via T-cell activation in mice.
Autorzy:
Mao Y; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Ge H; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Chen W; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Wang Y; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Liu H; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Li Z; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Bai Y; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Wang D; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Yu Y; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Zhen Q; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China; Anhui Provincial Institute of Translational Medicine, Hefei, China.
Li B; Integrated Laboratory, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Sun L; Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China; Health Science Center, North China University of Science and Technology, Tangshan 063210, China; North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China; Inflammation and Immune Diseases Laboratory of North China University of Science and Technology, Tangshan 063210, China; School of Public Health, North China University of Science and Technology, Tangshan, Hebei, 063210, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Sep; Vol. 122, pp. 110590. Date of Electronic Publication: 2023 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Vascular Endothelial Growth Factor A*/genetics
Vascular Endothelial Growth Factor A*/metabolism
Psoriasis*/chemically induced
Psoriasis*/genetics
Psoriasis*/drug therapy
Humans ; Animals ; Mice ; Imiquimod/pharmacology ; Skin/pathology ; Inflammation/metabolism ; Disease Models, Animal ; Mice, Inbred BALB C
Czasopismo naukowe
Szczegóły
Tytuł:
Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis.
Autorzy:
Chen C; Peking University Shenzhen Hospital, Shenzhen, China.
Che K; Peking University Shenzhen Hospital, Shenzhen, China.
Guo Y; Peking University Shenzhen Hospital, Shenzhen, China.
Huang Q; Peking University Shenzhen Hospital, Shenzhen, China.
Hu X; Peking University Shenzhen Hospital, Shenzhen, China.
Yu B; Peking University Shenzhen Hospital, Shenzhen, China.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2023 Sep; Vol. 50 (9), pp. 1156-1161. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/epidemiology
Psoriasis*/diagnosis
Diabetes Mellitus*/epidemiology
Humans ; Male ; Female ; Aged ; Retrospective Studies ; Age of Onset ; Comorbidity
Czasopismo naukowe
Szczegóły
Tytuł:
Comparative evaluation of efficacy and safety of calcipotriol versus calcitriol ointment, both in combination with narrow-band ultraviolet B phototherapy in the treatment of stable plaque psoriasis.
Autorzy:
Chakraborty D; Pandit BD Sharma University of Health Sciences, Rohtak, Rohtak, India.
Aggarwal K; Pandit BD Sharma University of Health Sciences, Rohtak, Rohtak, India.
Pokaż więcej
Źródło:
Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2023 Sep; Vol. 39 (5), pp. 512-519. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Dermatologic Agents*/adverse effects
Psoriasis*/drug therapy
Psoriasis*/radiotherapy
Humans ; Calcitriol ; Ointments/adverse effects ; Phototherapy ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry.
Autorzy:
Zimmer A; Asklepios Clinic Sankt Augustin, Kinderrheumatologie, Arnold-Janssen-Str. 29, 53757, Sankt Augustin, Germany. .
Klein A; Asklepios Clinic Sankt Augustin, Kinderrheumatologie, Arnold-Janssen-Str. 29, 53757, Sankt Augustin, Germany.
Kuemmerle-Deschner JB; Pädiatrische Rheumatologie and Autoinflammation Reference Center Tübingen, Klinik für Kinder- und Jugendmedizin, Member of ERN-RITA, Universitätsklinikum Tübingen, 72076, Tübingen, Germany.
Dressler F; Kinderklinik der Medizinischen Hochschule Hannover, Kinderrheumatologische Ambulanz, 30625, Hannover, Germany.
Onken N; Kinder- und Jugendärztliche Gemeinschaftspraxis, 21337, Lüneburg, Germany.
Brueck N; Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Fasshauer M; Städt. Klinikum St. Georg, Klinik für Kinder- und Jugendmedizin, 04129, Leipzig, Germany.
Hospach T; Olgahospital, Kinderrheumatologie, 70174, Stuttgart, Germany.
Hufnagel M; Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, Medical Faculty, University Medical Center Freiburg, University of Freiburg, 79106, Freiburg, Germany.
Foell D; Universitätsklinikum Münster, Klinik für Pädiatrische Rheumatologie und Immunologie, 48149, Munster, Germany.
Horneff G; Asklepios Clinic Sankt Augustin, Kinderrheumatologie, Arnold-Janssen-Str. 29, 53757, Sankt Augustin, Germany.
Pokaż więcej
Źródło:
Rheumatology international [Rheumatol Int] 2023 Sep; Vol. 43 (9), pp. 1675-1684. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Juvenile*/drug therapy
Antirheumatic Agents*/adverse effects
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Psoriasis*/chemically induced
Biological Products*/adverse effects
Humans ; Etanercept/adverse effects ; Tumor Necrosis Factor-alpha/therapeutic use ; Methotrexate/adverse effects ; Adalimumab/adverse effects ; Immunologic Factors/therapeutic use ; Registries
Czasopismo naukowe
Szczegóły
Tytuł:
Dyslipidemia initiates keratinocytes proliferation through upregulation of lncRNA NEAT in psoriasis patients.
Autorzy:
Mostafa A; Medical Biochemistry and Molecular Biology department, Faculty of Medicine, Cairo University, Cairo, Egypt. dr_.
Sabry D; Medical Biochemistry and Molecular Biology department, Faculty of Medicine, Cairo University, Cairo, Egypt.; Medical Biochemistry and Molecular Biology department, Faculty of Medicine, Badr University in Cairo, Badr City, Egypt.
Aboraia N; Dermatology department, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Fawzy A; Physiology department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Abou-Elalla AA; Medical Laboratory Technology department, Faculty of Applied Health Science Technology, Misr University for Science and Technology, 6th of October City, Egypt.
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2023 Sep; Vol. 50 (9), pp. 7597-7604. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Psoriasis*/genetics
Psoriasis*/metabolism
Dyslipidemias*/metabolism
Humans ; Up-Regulation/genetics ; Caspase 3/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Reactive Oxygen Species/metabolism ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor A/metabolism ; Inflammation/metabolism ; Keratinocytes/metabolism ; Cell Proliferation/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Epidemiology of Psoriasis in Portugal: A Population-Based Study.
Autorzy:
Torres T; Department of Dermatology. Centro Hospitalar Universitário do Porto. Porto; Instituto de Ciências Biomédicas Abel Salazar. University of Porto. Porto. Portugal.
Filipe P; Department of Dermatology. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisbon; Faculty of Medicine. University of Lisbon. Lisbon; Dermatology Research Unit. iMM João Lobo Antunes. University of Lisbon. Lisbon. Portugal.
Menezes Brandão F; Private practice. Lisbon. Portugal.
Figueiredo A; Faculty of Medicine. University of Coimbra. Coimbra. Portugal.
Pinto Soares A; Faculty of Medicine. University of Coimbra. Coimbra. Portugal.
Sousa Basto A; Private practice. Braga. Portugal.
Rebelo C; Department of Dermatology. Centro Hospitalar Universitário do Algarve. Faro. Portugal.
Correia O; Centro de Dermatologia Epidermis. Instituto CUF. Porto; Centre for Health Technology and Services Research. University of Porto; Basic and Clinical Immunology Unit. Department of Pathology. Faculty of Medicine. University of Porto. Portugal.
Ferreira P; Dermatology Center. Hospital CUF Descobertas. Lisbon. Portugal.
Brasileiro A; Department of Dermatology. Centro Hospitalar Universitário de Lisboa Central. Lisbon; NOVA Medical School. Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisbon. Portugal.
Mendes-Bastos P; Dermatology Center. Hospital CUF Descobertas. Lisbon. Portugal.
Paiva-Lopes MJ; Department of Dermatology. Centro Hospitalar Universitário de Lisboa Central. Lisbon; Chronic Diseases Research Center. NOVA Medical School. Faculdade de Ciências. Médicas. Universidade NOVA de Lisboa. Lisbon. Portugal.
Marques Pinto G; Department of Dermatology. Centro Hospitalar Universitário de Lisboa Central. Lisbon. Portugal.
Severo M; Departamento de Ensino Pré-Graduado. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional. Porto; Unidade de Investigação em Epidemiologia. Instituto de Saúde Pública. Universidade do Porto. Porto. Portugal.
Mendonça D; Departamento de Ensino Pré-Graduado. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional. Porto; Unidade de Investigação em Epidemiologia. Instituto de Saúde Pública. Universidade do Porto. Porto. Portugal.
Oliveira P; Departamento de Ensino Pré-Graduado. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional. Porto; Unidade de Investigação em Epidemiologia. Instituto de Saúde Pública. Universidade do Porto. Porto. Portugal.
Selores M; Department of Dermatology. Centro Hospitalar Universitário do Porto. Porto. Portugal.
Massa A; Private practice. Porto. Portugal.
Pereira M; Private practice. Porto. Portugal.
Tavares Bello R; Department of Dermatology. Hospital Lusíadas. Lisbon. Portugal.
Pokaż więcej
Corporate Authors:
the Portuguese Psoriasis Group of the Portuguese Society of Dermatology and Venereology
Źródło:
Acta medica portuguesa [Acta Med Port] 2023 Sep 01; Vol. 36 (9), pp. 541-549. Date of Electronic Publication: 2023 Jan 06.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/epidemiology
Psoriasis*/drug therapy
Arthritis, Psoriatic*/epidemiology
Arthritis, Psoriatic*/diagnosis
Humans ; Portugal/epidemiology ; Cross-Sectional Studies ; Skin/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment.
Autorzy:
Shih MC; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Li CL; Children's Medical Center, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Liao EC; Institute of Biomedical Sciences, MacKay Medical College, New Taipei City 252, Taiwan.; Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
Yen CY; Department of Dermatology, Taichung Veterans General Hospital, Taichung 407, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Integrated Care Center of Psoriatic Disease, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Yen LJ; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Wang KC; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; The Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Lu LY; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Chou TY; Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Chen YC; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Yu SJ; Integrated Care Center of Psoriatic Disease, Taichung Veterans General Hospital, Taichung 407, Taiwan.; Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.; Institute of Biomedical Sciences, College of Life Sciences, National Chung Hsing University, Taichung 407, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 31; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Inflammasomes*
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Animals ; Mice ; NLR Family, Pyrin Domain-Containing 3 Protein ; Quality of Life ; Caspase 1
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation of Keratinocytes and Alleviation of Psoriasis.
Autorzy:
Zhou Z; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.; School of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, People's Republic of China.
Liao B; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.
Wang S; Institute of Biomedical Transformation, School of Basic Medicine and Public Health, Jinan University, Guangzhou, 510632, People's Republic of China.
Tang J; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.
Zhao H; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.
Tong M; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.
Li K; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China.
Xiong S; Institute of Biomedicine and National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, People's Republic of China. xsh_.
Pokaż więcej
Źródło:
Archivum immunologiae et therapiae experimentalis [Arch Immunol Ther Exp (Warsz)] 2023 Aug 26; Vol. 71 (1), pp. 20. Date of Electronic Publication: 2023 Aug 26.
Typ publikacji:
Journal Article
MeSH Terms:
Fibroblast Growth Factor 2*
Psoriasis*/drug therapy
Animals ; Mice ; Escherichia coli ; Keratinocytes ; Humans
SCR Organism:
Komagataella pastoris
Czasopismo naukowe
Szczegóły
Tytuł:
Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model.
Autorzy:
Zhang G; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Xia Z; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Tian C; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Xia A; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China; Department of Ophthalmology and Research Laboratory of Macular Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
You J; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Liu J; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Yang S; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Li L; Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Aug 15; Vol. 92, pp. 129383. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Indazoles*/pharmacology
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Mice ; Animals ; Receptors, Aryl Hydrocarbon/agonists ; Skin/metabolism ; Imiquimod/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis.
Autorzy:
Rondags A; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. .
van Marle L; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Horváth B; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Wink FR; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Arends S; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Spoorenberg A; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2023 Aug 09; Vol. 25 (1), pp. 145. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Spondylarthritis*/complications
Spondylarthritis*/diagnosis
Spondylarthritis*/drug therapy
Spondylitis, Ankylosing*/drug therapy
Axial Spondyloarthritis*
Psoriasis*/complications
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Humans ; Surveys and Questionnaires
Czasopismo naukowe
Szczegóły
Tytuł:
The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options.
Autorzy:
Patel HA; Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC 27104, USA.
Revankar RR; The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Pedroza ST; Baylor College of Medicine, Houston, TX 77030, USA.
Graham S; Wright State University Boonshoft School of Medicine, Fairborn, OH 45435, USA.
Feldman SR; Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC 27104, USA.; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC 27104, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 01; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Genetic Predisposition to Disease*
Psoriasis*/drug therapy
Psoriasis*/genetics
Humans ; Interleukins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A case of successful treatment of concurrent verrucous epidermal naevi and psoriasis with apremilast.
Autorzy:
Dev PP; Department of Dermatology & STD, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Verma P; Department of Dermatology & STD, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2023 Aug; Vol. 64 (3), pp. e299-e301. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Case Reports
MeSH Terms:
Nevus, Sebaceous of Jadassohn*
Psoriasis*/complications
Psoriasis*/drug therapy
Skin Neoplasms*/complications
Skin Neoplasms*/drug therapy
Humans ; Acitretin/therapeutic use ; Treatment Outcome ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Severity of Illness Index
Raport
Szczegóły
Tytuł:
PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
Autorzy:
Antal D; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem ter 1., Elettudomanyi Epulet, H-4032, Debrecen, Hungary.; The Hungarian Academy of Sciences, Center of Excellence, Budapest, Hungary.
Pór Á; Department of Pathology, Gyula Kenézy Campus, Clinical Centre, University of Debrecen, Debrecen, Hungary.
Kovács I; Department of Pathology, Gyula Kenézy Campus, Clinical Centre, University of Debrecen, Debrecen, Hungary.
Dull K; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Póliska S; Genomic Medicine and Bioinformatics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Ujlaki G; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem ter 1., Elettudomanyi Epulet, H-4032, Debrecen, Hungary.; The Hungarian Academy of Sciences, Center of Excellence, Budapest, Hungary.
Demény MÁ; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem ter 1., Elettudomanyi Epulet, H-4032, Debrecen, Hungary.; The Hungarian Academy of Sciences, Center of Excellence, Budapest, Hungary.
Szöllősi AG; Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Kiss B; Department of Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Szegedi A; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; ELKH-DE Allergology Research Group, University of Debrecen, Debrecen, Hungary.
Bai P; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem ter 1., Elettudomanyi Epulet, H-4032, Debrecen, Hungary.; The Hungarian Academy of Sciences, Center of Excellence, Budapest, Hungary.; NKFIH-DE Lendület Laboratory of Cellular Metabolism, Debrecen, Hungary.; Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; MTA-DE Cell Biology and Signaling Research Group ELKH, Debrecen, Hungary.
Szántó M; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem ter 1., Elettudomanyi Epulet, H-4032, Debrecen, Hungary. .; The Hungarian Academy of Sciences, Center of Excellence, Budapest, Hungary. .
Pokaż więcej
Źródło:
Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2023 Aug; Vol. 101 (8), pp. 987-999. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dermatitis*/metabolism
Dermatitis*/pathology
Psoriasis*/genetics
Psoriasis*/metabolism
Animals ; Humans ; Mice ; Aromatase/metabolism ; Disease Models, Animal ; Imiquimod/adverse effects ; Inflammation/metabolism ; Keratinocytes/metabolism ; Mice, Inbred BALB C ; NF-kappa B/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerases/metabolism ; RNA, Messenger/metabolism ; Skin/metabolism
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 105308

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies